ZORAC

This brand name is authorized in Spain, New Zealand, Poland

Active ingredients

The drug ZORAC contains one active pharmaceutical ingredient (API):

1 Tazarotene UNII 81BDR9Y8PS - TAZAROTENE

Tazarotene, a member of the acetylenic class of retinoids, is a prodrug which is converted to its active free form, tazarotenic acid, by de-esterification in the skin area. Tazarotenic acid is the only known metabolite of tazarotene to have retinoid activity. Read about Tazarotene

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZORAC Gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D05AX05	Tazarotene	D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61861, 61862
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11596, 11597, 7683, 7684
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100105894, 100105902